WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees Pharmaceuticals, Inc., (“60P,”NASDAQ: SXTP; SXTPW) specialists in developing and marketing medicines for infectious diseases, has completed its previously announced Public Offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre funded units (the “Pre Funded Units”) at a price to the public of $0.375 per Pre Funded Unit. View Press Release Below.